"Percutaneous renal denervation in a drug-naive patient with multiple intolerances to antihypertensive agents reduced office and ambulatory blood pressure" Discover this new case and say how you would treat.
The Course Chairpersons invite you to join them in February to gain a better insight into the clinical relevance of target organ damage-guided therapy.
Submit until 7th February and take the chance to help build the next edition of the Course!
TRENDS & RHC are uniting their expertise and passion in the diagnosis and management of patients with resistant hypertension by combining their annual conferences.
On upcoming Clinical Consensus Conference on RDN on 9th December 2015!
Join RDN experts for a virtual symposium presented by Boston Scientific in collaboration with RHC.
Presented by J. Granada, M. Leon, F. Mahfoud and R. Schmieder.
Andrzej Januszewicz (Poland) answers the following questions:
- Do you screen every hypertensive patient for obstructive sleep apnea and why or why not?…